Evidence map›Paper›PMID 25157840›Full record

ReviewNature reviews. Nephrology2014

Economic evaluation of dialysis therapies.

Scott W Klarenbach, Marcello Tonelli, Betty Chui, Braden J Manns

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 107 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03474367 unknown statusnot on this mapstarted 2017, after this paper: background citation

Cost-effectiveness of Urgent-start Therapies Hemodialysis and Peritoneal Dialysis

TypeobservationalSponsorUniversidade Estadual Paulista Júlio de Mesquita FilhoRan2017 to 2021Enrolled198ConditionsCost-effectiveness Analysis, Chronic Kidney Disease Requiring Chronic Dialysis
NCT06396702 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Emotion And Symptom-focused Engagement (EASE) Intervention for the Management of Emotional and Physical Symptoms Among Solid Organ Transplant Recipients-pilot Study

TypeinterventionalSponsorUniversity Health Network, TorontoRan2024 to 2027Enrolled120ConditionsTransplant, Failure,Kidney, Transplant, Failure, HeartArmsEASE-SOT
3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Ten tips for the first hemodialysis sessions.Clinical kidney journal · 2026
    Review
  9. Article
  10. Increasing Access to Living Donor Kidney Transplantation: A Program Report.Canadian journal of kidney health and disease · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Scott W KlarenbachDivision of Nephrology, Department of Medicine, University of Alberta, 8440-112 Street, Edmonton, AB T6G 2G3, Canada.
Marcello TonelliDivision of Nephrology, Department of Medicine, University of Alberta, 8440-112 Street, Edmonton, AB T6G 2G3, Canada.
Betty ChuiDepartment of Medicine, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada.
Braden J MannsDivision of Nephrology, Department of Medicine, University of Calgary, Foothills Medical Center, 1403 29th Street NW, Calgary, AB T2N 2T9, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of chronic kidney disease and end-stage renal disease requiring dialysis therapy continues to increase worldwide, and despite technological advances, treatment remains resource intensive. Thus, the increasing burden of dialysis therapy on finite health-care budgets is an important consideration. The principles of allocative efficiency and the concept of 'opportunity cost' can be used to assess whether dialysis is economically justified; if dialysis is to be provided, cost-minimization and cost-utility analyses can be used to identify the most efficient dialysis modality. Existing studies have examined the cost, and where relevant the effectiveness, of the various currently available peritoneal dialysis and haemodialysis modalities. In this Review, we discuss variations in the intrinsic costs of the available dialysis modalities as well as other factors, such as variation by country, available health-care infrastructures, the timing of dialysis initiation and renal transplantation. We draw on data from robust micro-costing studies of the various dialysis modalities in Canada to highlight key issues.

Indexed as

Costs and Cost AnalysisHealth Care CostsDeveloped CountriesDeveloping CountriesFees and ChargesHumansKidney Failure, ChronicKidney TransplantationRenal DialysisResource AllocationTime FactorsTreatment Outcome

Identifiers

PMID25157840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.